Reckitt Benckiser chief Rakesh Kapoor to step down

Published On 2019-01-18 03:30 GMT   |   Update On 2021-08-18 06:16 GMT



One of UK's highest-paid CEOs Rakesh Kapoor will leave Reckitt Benckiser by end of 2019.








An Indian businessman, Kapoor joined RB when it was known, pre-merger with Benckiser, as Reckitt & Colman in 1987.

The company has now initiated a formal process to appoint Kapoor's successor, it said in a statement. RB product portfolio includes Dettol, Durex and Lysol. However, Kapoor said he will remain on the driving seat until his successor is found.


Kapoor has "indicated his intention to retire as CEO by the end of 2019, after more than eight years as CEO and 32 years at the company", the company said.


It further said that "RB's board has now initiated a formal process to appoint his successor, considering both internal and external candidates."


On his decision, Kapoor said: "It has been a huge privilege to lead RB and I am very proud of the hard work and commitment of our people in delivering our success and many achievements."


He added that the year 2020 will herald a new decade and it is a good time for the new leadership to take the company through the next phase of "outperformance".


RB chairman Chris Sinclair said: "On behalf of the board, I want to express our appreciation for his vision, passion and leadership over his long and distinguished tenure. We are now commencing a formal and comprehensive process to appoint a successor, considering both internal and external candidates."


Also Read: Reckitt Benckiser pulls out of Pfizer consumer health auction

Tags:    
Article Source : With input

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News